Small Molecules
Total Trials
9
As Lead Sponsor
As Collaborator
0
Total Enrollment
659
NCT00385515
Efficacy of SNX-1012 in the Treatment of Oral Mucositis
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2006
Completion: Jul 31, 2008
NCT02468128
A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management
Phase: Phase 2/3
Start: Dec 31, 2012
Completion: Apr 30, 2015
NCT02446301
A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers
Phase: Phase 1
Start: Jan 31, 2015
NCT04091945
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
Start: Jan 27, 2020
Completion: Mar 31, 2021
NCT04256434
A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.
Start: Jan 31, 2020
Completion: May 29, 2020
NCT04393675
Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients
Phase: Phase 1/2
Start: May 14, 2020
Completion: Mar 31, 2022
NCT04809818
A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects
Start: Mar 21, 2021
Completion: Oct 19, 2021
NCT05198323
A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
Start: Aug 11, 2022
Completion: Mar 31, 2026
NCT05403866
A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects
Start: Aug 17, 2022
Completion: May 23, 2025
Loading map...